Acute necrotizing pancreatitis

disease
On this page

Summary

Acute necrotizing pancreatitis (MONDO:0850420) is a disease and 14 clinical trials. A subtype of acute pancreatitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 14

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameacute necrotizing pancreatitis
Mondo IDMONDO:0850420
DOIDDOID:0080998
ICD-112063881303
UMLSC0267941
MedGen75645
Is cancer (heuristic)no

Disease family

This is a subtype of acute pancreatitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorderpancreas disorderpancreatitisacute pancreatitisacute necrotizing pancreatitis

Related subtypes (1): acute hemorrhagic pancreatitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 14.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified12
PHASE41
PHASE31

Top trials by phase / activity

NCTPhaseStatusTitle
NCT00995098PHASE4COMPLETEDEarly Enteral Nutrition for Severe Acute Pancreatitis
NCT07441824PHASE3RECRUITINGPancreatic Enzyme Replacement in Acute Necrotizing Pancreatitis
NCT07080697Not specifiedRECRUITINGA Study to Evaluate Splenectomy on Debridement for Acute Necrotizing Pancreatitis With Pancreatic Sinistral Portal Hypertension
NCT07253350Not specifiedRECRUITINGEffectiveness of Endorotor PED® System Versus Conventional Endoscopic Techniques for the Management of Walled-off Pancreatic Necrosis in Acute Necrotizing Pancreatitis: Randomized Single-blinded Controlled Superiority Trial and Cost-utility Analysis
NCT07308600Not specifiedNOT_YET_RECRUITINGIntegrating Plasma Metagenomics and Host Response for Accurate Diagnosis of Infected Pancreatic Necrosis in a Prospective Multicenter Cohort of Acute Necrotizing Pancreatitis
NCT01767233Not specifiedUNKNOWNProphylactic Pancreatic Duct Stenting in Acute Necrotizing Pancreatitis
NCT02641964Not specifiedCOMPLETEDRisk Factors for ARDS in Patients With Acute Necrotizing Pancreatitis
NCT03234166Not specifiedCOMPLETEDAcute Necrotizing Pancreatitis and Infected Pancreatic Necrosis
NCT03253861Not specifiedCOMPLETEDPancRea: Risk Factors and Outcomes of Infected Pancreatic Necrosis
NCT03411629Not specifiedCOMPLETEDSignificance of Collections Around Colon in Patients With Acute Necrotizing Pancreatitis
NCT04479228Not specifiedUNKNOWNPlastic Stents vs. NAGI Bi-flanged Metal Stent for Endoscopic Ultrasound Guided Drainage of Walled-off Necrosis
NCT04642794Not specifiedCOMPLETEDAcute Pancreatitis and Thrombosis (PATHRO)
NCT05716633Not specifiedUNKNOWNTracking ENcapsulation of Pancreatic Collections in Acute Necrotizing Pancreatitis
NCT05898048Not specifiedCOMPLETEDCMV Reactivation in Acute Necrotizing Pancreatitis

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.